KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$14.4 million.

  • Guardant Health's Cash from Investing Activities rose 9513.27% to -$14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $288.4 million, marking a year-over-year decrease of 2635.77%. This contributed to the annual value of -$261.3 million for FY2024, which is 13109.88% down from last year.
  • Guardant Health's Cash from Investing Activities amounted to -$14.4 million in Q3 2025, which was up 9513.27% from -$10.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash from Investing Activities registered a high of $663.5 million during Q4 2023, and its lowest value of -$294.8 million during Q3 2024.
  • In the last 5 years, Guardant Health's Cash from Investing Activities had a median value of $28.1 million in 2024 and averaged $49.7 million.
  • As far as peak fluctuations go, Guardant Health's Cash from Investing Activities plummeted by 23079.58% in 2023, and later skyrocketed by 97911.35% in 2025.
  • Over the past 5 years, Guardant Health's Cash from Investing Activities (Quarter) stood at -$266.7 million in 2021, then skyrocketed by 126.48% to $70.6 million in 2022, then soared by 839.38% to $663.5 million in 2023, then plummeted by 98.41% to $10.5 million in 2024, then tumbled by 236.28% to -$14.4 million in 2025.
  • Its Cash from Investing Activities stands at -$14.4 million for Q3 2025, versus -$10.6 million for Q2 2025 and $302.9 million for Q1 2025.